--  Net revenues of $298.1 million for the quarter ended June 28, 2009       compared to $344.2 million, which included net revenues of $79.3       million from its CareCentrix business unit, for the quarter ended June       29, 2008. Excluding prior year's second quarter net revenues from       CareCentrix, Gentiva's net revenues grew about $33 million, or 12% in       the 2009 second quarter. The Company sold a majority interest in       CareCentrix to Water Street Healthcare Partners on September 25, 2008.     --  Net income of $17.1 million, or $0.58 per diluted share compared to       net income of $12.0 million or $0.41 per diluted share in the 2008       second quarter.     --  Adjusted net income for the 2009 second quarter was $17.5 million, up       43% compared with the prior year period. On a diluted earnings per       share basis, adjusted net income in the 2009 second quarter was $0.59       compared with $0.42 in the corresponding period of 2008.  Adjusted net       income for both second quarter periods excludes special charges of       $0.01 per diluted share relating to restructuring and integration       activities.     --  Earnings before interest, taxes, depreciation and amortization       (EBITDA) increased 12% to $35.4 million in the second quarter of 2009.       EBITDA as a percentage of net revenues improved to 11.9% in the second       quarter of 2009 versus 9.2% in the prior-year period. EBITDA included       restructuring and integration costs of $0.6 million in the second       quarter of 2009 as compared to $0.4 million for the prior year period.   

"Gentiva had a very good second quarter driven by continued success in executing our core strategies: rolling out our specialty programs, serving the needs of higher acuity seniors and increasing both the capacity and productivity of our growing clinician base," said Gentiva CEO Tony Strange. "Our performance demonstrates the commitment of our employees as well as the growing belief of the healthcare community in the power of home care as a key part of the solution to the nation's healthcare challenges."

   Gentiva reported these segment highlights for the quarter:     --  Home Health revenue growth of 12% to $265.6 million and operating       contribution growth of 23% to $48.6 million.     --  Revenues in the All Other segment - which includes hospice,       respiratory therapy and home medical equipment, infusion therapy and       consulting - increased 14% to $33.0 million, while operating       contribution increased 19% to $3.9 million compared to the prior-year       period.    Gentiva reported these highlights for the six months ended June 28, 2009:     --  Net revenues of $587.0 million versus $665.8 million in the prior year       period.  Net revenues in the 2008 period included approximately $157       million relating to CareCentrix.  Excluding the revenue contribution       from CareCentrix, Gentiva's net revenues grew about $77 million, or       15%, in the six-month period ended June 28, 2009.     --  Net income of $35.1 million, or $1.19 per diluted share which included       (i) a non-recurring pre-tax net gain of $5.7 million or $0.20 per       diluted share resulting from the 2009 first quarter sale of certain       branch offices that specialized primarily in pediatric home health       care services and (ii) special pre-tax charges of $1.5 million or       $0.03 per diluted share relating to restructuring and integration       costs. These results compared to net income of $19.7 million or $0.68       per diluted share in the 2008 period which included special pre-tax       charges of $0.7 million or $0.01 per diluted share relating to       restructuring and integration costs.     --  Adjusted net income was $30.2 million, up 50% compared with the prior       year period. On a diluted earnings per share basis, adjusted net       income in the 2009 period was $1.02 compared with $0.69 in the       corresponding period of 2008.     --  EBITDA increased 15% to $63.6 million versus $55.3 million in the       prior-year period.     --  Operating cash flow was $49.5 million in the 2009 period compared to       $20.8 million in the comparable 2008 period.   

At June 28, 2009, the Company reported cash and cash equivalents of $99.5 million and long-term debt of $237 million.

Full-Year 2009 Outlook

Gentiva announced that it is raising its revenue and earnings outlook for fiscal 2009 based on its year-to- date performance and prospects for the remainder of this year. Gentiva now anticipates full-year 2009 net revenues will range between $1.19 billion to $1.21 billion, as compared to prior guidance of $1.14 billion to $1.18 billion. On a diluted earnings per share basis, adjusted net income is expected to be in a range between $2.04 and $2.10, up from the $1.72 and $1.80 range provided earlier this year. Gentiva's 2009 outlook represents an increase in net revenues of 12% to 14% and an increase in diluted earnings per share of 45% to 50% when compared with 2008 pro forma financial results, which reflect the Company's performance as if the CareCentrix divestiture had occurred at the beginning of fiscal 2008. The 2009 outlook excludes special charges relating to restructuring and integration costs which are expected to range between $3 million and $4 million for the year and non-recurring charges and credits. The outlook includes the impact of recently announced acquisitions and also reflects 53 weeks of activity in fiscal 2009.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its second quarter 2009 results during its conference call and live web cast to be held Thursday, July 30, 2009 at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #19324792. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log onto http://investors.gentiva.com/events.cfm to hear the web cast. A replay of the call will be available on July 30, beginning at approximately 1 p.m. ET, and will remain available continuously through August 6. To listen to a replay of the call from the United States, Canada or international locations, dial (800) 642-1687 or (706) 645-9291 and enter the following PIN at the prompt: 19324792. Visit http://investors.gentiva.com/events.cfm to access the web cast archive. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 48 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. For more information, visit Gentiva's web site, http://www.gentiva.com/, and its investor relations section at http://investors.gentiva.com/.